-
SCPH Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
scPharmaceuticals (SCPH)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 91.48 mm | 91.48 mm | 91.48 mm | 91.48 mm | 91.48 mm | 91.48 mm |
Cash burn (monthly) | (no burn) | (no burn) | 6.05 mm | 5.31 mm | 5.81 mm | 5.88 mm |
Cash used (since last report) | n/a | n/a | 16.93 mm | 14.86 mm | 16.26 mm | 16.45 mm |
Cash remaining | n/a | n/a | 74.55 mm | 76.63 mm | 75.23 mm | 75.04 mm |
Runway (months of cash) | n/a | n/a | 12.3 | 14.4 | 13.0 | 12.8 |
13F holders | Current |
---|---|
Total holders | 45 |
Opened positions | 18 |
Closed positions | 40 |
Increased positions | 12 |
Reduced positions | 8 |
13F shares | Current |
---|---|
Total value | 48.73 bn |
Total shares | 20.75 mm |
Total puts | 2.60 k |
Total calls | 39.20 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Orbimed Advisors | 5.56 mm | $24.18 bn |
Hirschman Orin | 2.55 mm | $17.77 mm |
Cowen Financial Products | 2.41 mm | $22.63 mm |
5AM Ventures IV | 2.32 mm | $0.00 |
King Luther Capital Management | 2.22 mm | $9.57 mm |
5AM Venture Management | 1.20 mm | $5.22 bn |
J. Goldman & Co | 870.34 k | $3.79 bn |
Citadel Advisors | 735.40 k | $3.20 bn |
STT State Street | 648.26 k | $2.82 bn |
Stonepine Capital Management | 421.70 k | $1.83 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Aug 24 | Schaeffer Leonard D | Common Stock | Option exercise | Acquire M | No | No | 3.37 | 6,124 | 20.64 k | 54,451 |
26 Aug 24 | Schaeffer Leonard D | Common Stock | Option exercise | Acquire M | No | No | 1.66 | 5,223 | 8.67 k | 48,327 |
26 Aug 24 | Schaeffer Leonard D | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.37 | 6,124 | 20.64 k | 0 |
26 Aug 24 | Schaeffer Leonard D | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.66 | 5,223 | 8.67 k | 0 |
13 Aug 24 | Orbimed Advisors | Common Stock | Buy | Acquire P | Yes | No | 4 | 21,658 | 86.63 k | 252,858 |
13 Aug 24 | Orbimed Advisors | Common Stock | Buy | Acquire P | Yes | No | 4 | 478,342 | 1.91 mm | 5,806,670 |
6 Aug 24 | Rachael Nokes | Common Stock | Option exercise | Acquire M | No | No | 1.66 | 10,445 | 17.34 k | 72,851 |
11 Jun 24 | Veitinger Klaus R DR | Stock Option Common Stock | Grant | Acquire A | No | No | 4.11 | 19,750 | 81.17 k | 19,750 |
11 Jun 24 | Baylor-Henry Minnie | Stock Option Common Stock | Grant | Acquire A | No | No | 4.11 | 19,750 | 81.17 k | 19,750 |